Top compounds associated with response to PLCB3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.02
mRNA Bosutinib GDSC1000 pan-cancer AAC 0.094 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.02
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.096 0.02
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.093 0.02
mRNA necrostatin-7 CTRPv2 pan-cancer AAC -0.1 0.02
mRNA myricetin CTRPv2 pan-cancer AAC -0.11 0.02
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.02
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.097 0.02
mRNA ML050 CTRPv2 pan-cancer AAC -0.1 0.02
Download CSV